Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06966492 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.

Study acronym: ILIMSIR
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 2026 to Sep 2026v6
  2. Primary and study completion pushed from Dec 2026 to Jun 2027
    • Start date: May 2026 to Jun 2026
    v5
  3. Start date: Mar 2026 to May 2026v4
  4. Start date: Oct 2025 to Mar 2026
    • Study sites: 0 to 1
    • Primary completion date: Jun 2026 to Dec 2026
    • Study completion date: Jul 2026 to Dec 2026
    v3
  5. Study description expanded, about 66 wordsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a clinical research study designed to measure changes in inflammation and the oral microbiome during a phase of good oral hygiene and the absence of oral hygiene. The goal of the study is to investigate the interplay between local oral inflammation, microbiota and systemic immune responses.
Trial Details
NCT Number NCT06966492
Lead Sponsor Colgate Palmolive
Collaborators: The University of Texas Health Science Center, Houston
Conditions
(from sponsor)		 Gingival Inflammation
Related terms Gingivitis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov